Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-25 4:56 pm Purchase |
2023-09-14 | 13G | Disc Medicine, Inc. IRON |
Paradigm BioCapital Advisors LP | 1,235,918 5.400% |
1,235,918 (New Position) |
Filing History |
| 2023-09-13 5:22 pm Purchase |
2023-09-12 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,803,600 14.300% |
5,288,489 (+210.27%) |
Filing History |
| 2023-07-21 4:44 pm Purchase |
2023-07-11 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 2,422,700 5.050% |
2,422,700 (New Position) |
Filing History |
| 2023-07-10 5:00 pm Purchase |
2023-06-30 | 13G | Autolus Therapeutics plc AUTL |
Paradigm BioCapital Advisors LP | 10,098,584 5.800% |
10,098,584 (New Position) |
Filing History |
| 2023-05-11 4:26 pm Purchase |
2023-05-01 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 2,310,698 5.400% |
419,531 (+22.18%) |
Filing History |
| 2023-04-10 4:33 pm Purchase |
2023-03-29 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 2,515,111 6.200% |
2,515,111 (New Position) |
Filing History |
| 2023-02-24 4:54 pm Purchase |
2023-02-14 | 13G | Bicycle Therapeutics plc BCYC |
Paradigm BioCapital Advisors LP | 1,610,665 5.400% |
1,610,665 (New Position) |
Filing History |
| 2023-02-14 4:59 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 1,891,167 4.700% |
682,116 (+56.42%) |
Filing History |
| 2023-02-14 4:59 pm Sale |
2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
Paradigm BioCapital Advisors LP | 0 0.000% |
-1,462,576 (Position Closed) |
Filing History |
| 2023-02-14 4:58 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Paradigm BioCapital Advisors LP | 2,317,634 5.050% |
102,912 (+4.65%) |
Filing History |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 6,477,999 9.900% |
4,149,505 (+178.21%) |
Filing History |
| 2022-10-27 4:47 pm Purchase |
2022-10-17 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 2,328,494 6.100% |
2,328,494 (New Position) |
Filing History |
| 2022-10-03 5:16 pm Purchase |
2022-09-23 | 13G | Alpine Immune Sciences, Inc. ALPN |
Paradigm BioCapital Advisors LP | 2,214,722 5.030% |
2,214,722 (New Position) |
Filing History |
| 2022-07-18 4:24 pm Purchase |
2022-07-07 | 13G | Oyster Point Pharma, Inc. OYST |
Paradigm BioCapital Advisors LP | 1,462,576 5.500% |
1,462,576 (New Position) |
Filing History |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 1,209,051 5.570% |
1,209,051 (New Position) |
Filing History |